Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study

Hui-Chuan Sun,1,* Zhi-Yong Huang,2,* Tianfu Wen,3,* Lianxin Liu,4,* Xiao-Dong Zhu,1,* Erlei Zhang,2 Chuan Li,3 Xiaoyun Zhang,3 Jiabei Wang,4 Jia Fan,1 Jian Zhou1 1Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer I...

Full description

Saved in:
Bibliographic Details
Main Authors: Sun HC, Huang ZY, Wen T, Liu L, Zhu XD, Zhang E, Li C, Zhang X, Wang J, Fan J, Zhou J
Format: Article
Language:English
Published: Dove Medical Press 2025-05-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
Online Access:https://www.dovepress.com/adjuvant-lenvatinib-for-high-risk-cnlc-iibiiia-hepatocellular-carcinom-peer-reviewed-fulltext-article-JHC
Tags: Add Tag
No Tags, Be the first to tag this record!